Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Gydesen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Neuropathology and Experimental Neurology|September 25, 2003
Tau protein in frontotemporal dementia linked to chromosome 3 (FTD-3)Despina Yancopoulou, R Anthony Crowther, Lisa Chakrabarti, et al.
Dementia and Geriatric Cognitive Disorders|June 5, 2004
Frontotemporal dementia linked to chromosome 3Jerry Brown, Susanne Gydesen, Peter Johannsen, et al.
Journal of Clinical Psychopharmacology|February 28, 2012
Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled studyJimmi Nielsen, Charlotte Emborg, Susanne Gydesen, et al.
Neurobiology of Aging|September 11, 2017
TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3)Nina Rostgaard, Peter Roos, Esben Budtz-Jørgensen, et al.
Acta Neurologica Scandinavica|January 8, 2022
Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survivalPeter Roos, Peter Johannsen, Suzanne G Lindquist, et al.
Nature Genetics|July 26, 2005
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementiaGaia Skibinski, Nicholas J Parkinson, Jeremy M Brown, et al.
Lupus Science & Medicine|March 18, 2026
Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trialsKathryn Connelly, Eric Morand, Rachel Koelmeyer, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Neuropathology and Experimental Neurology|September 25, 2003
Tau protein in frontotemporal dementia linked to chromosome 3 (FTD-3)Despina Yancopoulou, R Anthony Crowther, Lisa Chakrabarti, et al.
Dementia and Geriatric Cognitive Disorders|June 5, 2004
Frontotemporal dementia linked to chromosome 3Jerry Brown, Susanne Gydesen, Peter Johannsen, et al.
Journal of Clinical Psychopharmacology|February 28, 2012
Augmenting clozapine with sertindole: a double-blind, randomized, placebo-controlled studyJimmi Nielsen, Charlotte Emborg, Susanne Gydesen, et al.
Neurobiology of Aging|September 11, 2017
TMEM106B and ApoE polymorphisms in CHMP2B-mediated frontotemporal dementia (FTD-3)Nina Rostgaard, Peter Roos, Esben Budtz-Jørgensen, et al.
Acta Neurologica Scandinavica|January 8, 2022
Six generations of CHMP2B-mediated Frontotemporal Dementia: Clinical features, predictive testing, progression, and survivalPeter Roos, Peter Johannsen, Suzanne G Lindquist, et al.
Nature Genetics|July 26, 2005
Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementiaGaia Skibinski, Nicholas J Parkinson, Jeremy M Brown, et al.
Lupus Science & Medicine|March 18, 2026
Measurement of haemolytic anaemia in a novel treatment response measure for SLE clinical trialsKathryn Connelly, Eric Morand, Rachel Koelmeyer, et al.
Pageof 1